Skip to main content
AVECHO BIOTECHNOLOGY LIMITED logo

AVECHO BIOTECHNOLOGY LIMITED — Investor Relations & Filings

Ticker · AVE ISIN · AU0000047441 LEI · 529900FA9G9T82C2LV25 ASX Manufacturing
Open in API
Filings indexed 881 across all filing types
Latest filing 2017-10-08 Capital/Financing Update
Country AU Australia
Listing ASX AVE

About AVECHO BIOTECHNOLOGY LIMITED

https://avecho.com.au/

Avecho Biotechnology Limited develops and commercializes human and animal health products using its proprietary drug delivery system, Tocopheryl Phosphate Mixture (TPM®). Derived from Vitamin E, TPM® is designed to enhance the solubility and absorption of active ingredients through the skin and digestive tract. The company focuses on applying this technology to pharmaceuticals, nutraceuticals, and animal health sectors. A primary area of development includes medicinal cannabis, where Avecho has produced high-bioavailability cannabidiol (CBD) softgel capsules for therapeutic use. The company’s portfolio also includes applications in pain management and dermatology, leveraging TPM® to improve the delivery of poorly soluble molecules and enhance the efficacy of existing treatments.

Recent filings

Filing Released Lang Actions
Phosphagenics Extension of Closing Date of Entitlement Offer 1
Capital/Financing Update Classification · 95% confidence The document is an announcement from Phosphagenics Limited regarding the extension of the closing date for a non-renounceable pro-rata entitlement offer, which is a fundraising activity involving the issuance of new shares. The text includes details about the revised timetable for the entitlement offer and contact information for further inquiries. There is no financial data, report, or detailed analysis presented, only an update on the capital raising process. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length is short and focused solely on the entitlement offer extension, confirming it is not a full report or regulatory filing.
2017-10-08 English
Phosphagenics Newsletter - October 2017 5 pages 211.1KB
Investor Presentation Classification · 90% confidence The document is a shareholder newsletter from October 2017, providing updates on company activities such as the sale of a brand, development agreements, arbitration progress, a capital raising entitlement offer, and other operational milestones. It is not a formal financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a transcript of a call or a regulatory filing. The content is more of a communication to shareholders summarizing recent developments and encouraging participation in a rights issue. It does not contain detailed financial statements or audit information. It also does not fit into categories like M&A filings, director dealings, or governance reports. Given the nature of the document as a shareholder newsletter with updates and announcements, it best fits the category of an Investor Presentation (IP) or possibly a Regulatory Filing (RNS). However, since it is a newsletter with detailed updates and strategic information aimed at investors, the closest specific category is Investor Presentation (IP). The document length and detail support this classification with high confidence.
2017-10-03 English
CEO Quarterly Update Teleconference 2 pages 115.9KB
Regulatory Filings Classification · 95% confidence The document is an announcement inviting interested parties to participate in a teleconference for a CEO Quarterly Update. It provides details for joining the call, including date, time, dial-in numbers, and instructions for Q&A. There is no substantive financial data, analysis, or report content included. The document length is 3313 characters, which is relatively short and consistent with an announcement rather than a full report. The content is clearly about a conference call related to quarterly updates, which aligns with a Call Transcript or a Call Announcement. However, since this document is an invitation and instructions for a teleconference rather than the transcript of the call itself, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit other categories more specifically. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2017-10-03 English
Phosphagenics Entitlement Offer Information Booklet 36 pages 681.2KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Entitlement Offer Information Booklet' and describes a pro rata non-renounceable entitlement offer of new shares to existing shareholders. It includes detailed information about the offer, how to apply, underwriting, eligibility, and other procedural details. The document is not a prospectus but an information booklet related to a capital raising event. There is no indication of financial statements, audit information, or management discussion of financial results. The content focuses on the capital raising process and share issuance. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the full offer document, not just an announcement or a brief summary, supporting a high confidence classification as CAP.
2017-10-02 English
Despatch of Entitlement Offer Forms and Information Booklet 1
Capital/Financing Update Classification · 95% confidence The document is a short announcement dated 3 October 2017 from Phosphagenics Limited regarding the despatch of an Information Booklet and Entitlement & Acceptance Form for a non-renounceable pro-rata entitlement offer. It informs shareholders about the distribution of these documents and provides instructions for participation in the offer. There is no detailed financial data or report content, only an update on the distribution of offer materials related to a capital raising event. This fits the category of a Capital/Financing Update (CAP) rather than a full report or regulatory filing. The document length is short (1476 characters), and it is clearly an announcement about financing activity.
2017-10-02 English
Phosphagenics Entitlement Offer - Eligible Shareholders 3 pages 1.3MB
Regulatory Filings
2017-09-27 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.